Vera Therapeutics Inc Class A (VERA)
SG&A Expenses
$52.41M
Quarterly · Period ending: · USD
VERA SG&A Expenses
Latest reported$52.41Mperiod ending
Latest reported$52.41Mperiod ending
VERA Quarterly SG&A Expenses ($1.03M → $52.41M)
Quarterly SG&A Expenses
High-resolution chart · PNG
VERA sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 52,410,000 | |
| 39,121,000 | |
| 34,896,000 | |
| 27,459,000 | |
| 21,946,000 | |
| 15,916,000 | |
| 15,567,000 | |
| 9,487,000 | |
| 8,032,000 | |
| 7,395,000 | |
| 5,711,000 | |
| 5,656,000 | |
| 5,739,000 | |
| 6,150,000 | |
| 6,905,000 | |
| 5,588,000 | |
| 4,945,000 | |
| 4,472,000 | |
| 3,832,000 | |
| 3,688,000 | |
| 2,614,000 | |
| 1,784,000 | |
| 1,136,000 | |
| 652,000 | |
| 1,219,000 | |
| 1,032,000 |